Association of remnant cholesterol with frailty: findings from observational and Mendelian randomization analyses

[21] Cella A(2008)A standard procedure for creating a frailty index BMC Geriatr 8 1095254-752

[22] Demurtas J(2015)Frailty in NHANES: comparing the frailty index and phenotype Arch Gerontol Geriatr 60 604-698

[23] Zora S(2016)Development and validation of an electronic frailty index using routine primary care electronic health record data Age Ageing 45 740-4853

[24] Maggi S(2022)Secondhand smoke is positively associated with pre-frailty and frailty in non-smoking older adults Front Psychiatry 13 e34408-331

[25] Damluji AA(2009)A new equation to estimate glomerular filtration rate Ann Intern Med. 150 693-743

[26] Chung S-E(2022)Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation PLoS Biol 20 4851-626

[27] Xue Q-L(2021)A genome-wide association study of the frailty index highlights brain pathways in ageing Aging Cell 20 314-1262

[28] Hasan RK(2011)Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants Int J Epidemiol 40 738-undefined

[29] Moscucci M(2017)Orienting the causal relationship between imprecisely measured traits using GWAS summary data PLoS Genet 13 206-undefined

[30] Forman DE(2018)The MR-Base platform supports systematic causal inference across the human phenome Loos R, editor. eLife 7 615-undefined

[21] Cella A(2008)A standard procedure for creating a frailty index BMC Geriatr 8 1095254-752

[22] Demurtas J(2015)Frailty in NHANES: comparing the frailty index and phenotype Arch Gerontol Geriatr 60 604-698

[23] Zora S(2016)Development and validation of an electronic frailty index using routine primary care electronic health record data Age Ageing 45 740-4853

[24] Maggi S(2022)Secondhand smoke is positively associated with pre-frailty and frailty in non-smoking older adults Front Psychiatry 13 e34408-331

[25] Damluji AA(2009)A new equation to estimate glomerular filtration rate Ann Intern Med. 150 693-743

[26] Chung S-E(2022)Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation PLoS Biol 20 4851-626

[27] Xue Q-L(2021)A genome-wide association study of the frailty index highlights brain pathways in ageing Aging Cell 20 314-1262

[28] Hasan RK(2011)Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants Int J Epidemiol 40 738-undefined

[29] Moscucci M(2017)Orienting the causal relationship between imprecisely measured traits using GWAS summary data PLoS Genet 13 206-undefined

[30] Forman DE(2018)The MR-Base platform supports systematic causal inference across the human phenome Loos R, editor. eLife 7 615-undefined